X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22854) 22854
Newspaper Article (16176) 16176
Newsletter (10734) 10734
Book Review (3682) 3682
Publication (2286) 2286
Magazine Article (714) 714
Trade Publication Article (625) 625
Web Resource (486) 486
Book Chapter (155) 155
Conference Proceeding (149) 149
Dissertation (136) 136
Book / eBook (76) 76
Transcript (65) 65
Streaming Video (38) 38
Report (23) 23
Reference (19) 19
Government Document (9) 9
Data Set (5) 5
Journal / eJournal (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human papillomavirus (26086) 26086
vaccines (22263) 22263
cervical cancer (20890) 20890
papillomavirus infections (20555) 20555
index medicus (15315) 15315
humans (14603) 14603
female (11775) 11775
cancer (11408) 11408
immunization (10998) 10998
research (9276) 9276
vaccination (7194) 7194
medical research (7146) 7146
health aspects (6724) 6724
papillomaviruses (6233) 6233
adult (5905) 5905
medicine, experimental (5827) 5827
womens health (5060) 5060
women (5010) 5010
papillomavirus infections - prevention & control (4980) 4980
prevention (4892) 4892
adolescent (4774) 4774
cancer vaccines (4405) 4405
oncology (3991) 3991
male (3895) 3895
middle aged (3870) 3870
infection (3855) 3855
care and treatment (3540) 3540
studies (3518) 3518
uterine cervical neoplasms - prevention & control (3444) 3444
uterine cervical neoplasms - virology (3309) 3309
young adult (3255) 3255
immunology (3252) 3252
public health (3164) 3164
risk factors (3080) 3080
analysis (3070) 3070
papillomavirus infections - virology (3043) 3043
hpv (3042) 3042
oncology, experimental (2976) 2976
infections (2971) 2971
prevalence (2932) 2932
papillomavirus infections - epidemiology (2774) 2774
infectious diseases (2543) 2543
papillomavirus vaccines - administration & dosage (2543) 2543
cervical-cancer (2364) 2364
medical screening (2303) 2303
diagnosis (2252) 2252
animals (2173) 2173
universities and colleges (2133) 2133
child (2121) 2121
reports (2121) 2121
papillomavirus vaccines (2055) 2055
epidemiology (2049) 2049
papillomavirus infections - complications (1997) 1997
public, environmental & occupational health (1994) 1994
human-papillomavirus (1992) 1992
aged (1978) 1978
papillomaviridae - genetics (1861) 1861
medicine, research & experimental (1808) 1808
immunotherapy (1756) 1756
vaccine (1730) 1730
sexually transmitted diseases (1689) 1689
dna (1687) 1687
risk (1678) 1678
pharmaceutical industry (1662) 1662
viruses (1660) 1660
united-states (1658) 1658
virology (1648) 1648
papillomaviridae - isolation & purification (1605) 1605
papillomavirus vaccines - immunology (1506) 1506
clinical trials (1504) 1504
papillomavirus infections - diagnosis (1481) 1481
young-women (1467) 1467
uterine cervical neoplasms - epidemiology (1453) 1453
virus diseases (1450) 1450
article (1448) 1448
health knowledge, attitudes, practice (1430) 1430
abridged index medicus (1411) 1411
papillomavirus vaccines - therapeutic use (1368) 1368
medicine (1296) 1296
medicine, general & internal (1285) 1285
age (1283) 1283
obstetrics & gynecology (1279) 1279
mice (1271) 1271
genetic aspects (1270) 1270
teenagers (1270) 1270
research article (1250) 1250
papillomavirus infections - immunology (1243) 1243
genotype (1237) 1237
proteins (1237) 1237
uterine cervical neoplasms - diagnosis (1235) 1235
tumors (1227) 1227
papillomaviridae - immunology (1226) 1226
cervical intraepithelial neoplasia (1225) 1225
cervix (1200) 1200
deoxyribonucleic acid--dna (1181) 1181
pediatrics (1180) 1180
hpv vaccine (1178) 1178
intraepithelial neoplasia (1175) 1175
microbiology (1125) 1125
particle vaccine (1116) 1116
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (41) 41
Gerstein Science - Stacks (23) 23
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Searching (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Government Pubs (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50660) 50660
French (333) 333
Spanish (279) 279
German (222) 222
Chinese (99) 99
Portuguese (58) 58
Korean (50) 50
Japanese (47) 47
Italian (35) 35
Polish (32) 32
Danish (29) 29
Swedish (28) 28
Czech (22) 22
Norwegian (20) 20
Russian (18) 18
Dutch (17) 17
Turkish (9) 9
Bulgarian (8) 8
Hungarian (7) 7
Croatian (5) 5
Finnish (5) 5
Hebrew (4) 4
Persian (3) 3
Slovenian (3) 3
Serbian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Hindi (1) 1
Icelandic (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Reference
Journal Article
Vaccine, ISSN 0264-410X, 06/2016, Volume 34, Issue 31, pp. 3562 - 3567
Journal Article
Vaccine, ISSN 0264-410X, 01/2018, Volume 36, Issue 1, pp. 98 - 106
Journal Article
Side Effects of Drugs Annual, ISSN 0378-6080, 2016, Volume 38, pp. 307 - 334
Journal Article
Side Effects of Drugs Annual, ISSN 0378-6080, 2015, Volume 37, pp. 383 - 401
Conference Proceeding
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2015, Volume 11, Issue 7, pp. 1689 - 1702
This observer-blind study (clinicaltrials.gov NCT01462357) compared the immunogenicity and safety of 2 doses of the HPV-16/18 AS04-adjuvanted vaccine... 
y, year(s) | AAHS, aluminum hydroxyphosphate sulfate | CI, confidence interval | PBMC, peripheral blood mononuclear cells | ELISA, enzyme-linked immunosorbent assay | M, month(s) | ELISPOT, enzyme-linked immunosorbent spot assay | human papillomavirus (HPV) vaccines | HPV-6/11/16/18(3D), 3-dose schedule of the HPV-6/11/16/18 vaccine | safety | ANOVA, analysis of variance | female adolescents | 50 | PBNA, pseudovirion-based neutralisation assay | GMT, geometric mean antibody titer | ED | 2D, 2-dose | AS04, Adjuvant System containing 50 µg 3-O-desacyl-4 ′-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al | CMI, cell-mediated immunity | 3D, 3-dose | ) | SAE, serious adverse event | immunogenicity | HPV, human papillomavirus | IgG, immunoglobulin G | TVC, total vaccinated cohort | 3 | ATP-I, according-to-protocol immunogenicity cohort | effective dose producing 50% response | HPV-16/18(2D), 2-dose schedule of the HPV-16/18 vaccine | IFNγ, interferon | VLP, virus-like particle | administration schedule | GMR, geometric mean titer ratio | EU, ELISA unit | HPV-6/11/16/18(2D), 2-dose schedule of the HPV-6/11/16/18 vaccine | pIMD, potential immune-mediated disease | Administration schedule | Safety | Immunogenicity | Human papillomavirus (HPV) vaccines | Female adolescents | PBNA | TVC | enzyme-linked immunosorbent spot assay | pIMD | CLINICAL-TRIAL | potential immune-mediated disease | OF-STUDY ANALYSIS | ELISA unit | IMMUNOLOGY | NEUTRALIZATION ASSAY | 18(3D) | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | geometric mean antibody titer | BLIND PATRICIA TRIAL | CMI | 2-dose | pseudovirion-based neutralisation assay | AS04 | CERVICAL-CANCER | GMR | PBMC | GMT | MEMORY B-CELLS | according-to-protocol immunogenicity cohort | AAHS | PARTICLE VACCINE | SAE | human papillomavirus | HPV VACCINE | ELISA | ATP-I | month(s) | virus-like particle | 3-dose | geometric mean titer ratio | IgG | 2-dose schedule of the HPV-16 | HPV | 18 vaccine | IFN | 18(2D) | CD154 EXPRESSION | analysis of variance | ANOVA | serious adverse event | total vaccinated cohort | year(s) | ED50 | VLP | YOUNG-WOMEN | Adjuvant System containing 50 mu g 3-O-desacyl-4-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 mu g Al3+) | peripheral blood mononuclear cells | aluminum hydroxyphosphate sulfate | immunoglobulin G | 3-dose schedule of the HPV-6 | HPV-16 | HPV-6 | 2-dose schedule of the HPV-6 | interferon | ELISPOT | enzyme-linked immunosorbent assay | confidence interval | cell-mediated immunity | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - adverse effects | Adjuvants, Immunologic - administration & dosage | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology | Vaccine Potency | Humans | Alphapapillomavirus - immunology | Antibodies, Viral - blood | Immunity, Humoral | Time Factors | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - adverse effects | Female | Immunization Schedule | Papillomavirus Vaccines - immunology | Child | Immunity, Cellular | Papillomavirus Vaccines - administration & dosage | Antibodies, Neutralizing - blood | Index Medicus | Medical and Health Sciences | Basic Medicine | Medicinsk bioteknologi | Medical Biotechnology | Medicin och hälsovetenskap | Immunologi inom det medicinska området | Immunology in the medical area | Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) | Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinska och farmaceutiska grundvetenskaper
Journal Article
The American Journal of Nursing, ISSN 0002-936X, 01/2012, Volume 112, Issue 1, p. 16
Backlash against human papillomavirus (HPV) vaccination in girls continued, particularly over making it a requirement for school attendance, with politicians... 
Side effects | Human papillomavirus | Vaccines
Journal Article
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 05/2015, Volume 9, Issue 5, pp. e0003598 - e0003598
  The requirement to receive three doses of HPV vaccine has complicated the achievement of high coverage. [...]post-licensure research is focused on... 
HUMAN-PAPILLOMAVIRUS VACCINE | PARASITOLOGY | TROPICAL MEDICINE | Prevention | Schistosomiasis | Patient outcomes | Hepatitis B vaccine | Dosage and administration | Methods | Cancer | Human papillomavirus | Product development | Infections | Vaccines | Bladder cancer | Cervical cancer | Public health | Tropical diseases | Eggs
Journal Article
Side Effects of Drugs Annual, ISSN 0378-6080, 2014, Volume 36, pp. 465 - 482
Journal Article
Vaccine, ISSN 0264-410X, 05/2019, Volume 37, Issue 25, pp. 3290 - 3295
Vaccines are excellent investments with far-reaching rewards beyond individual and population health, but their introduction into national programs has been... 
Decade of vaccines | Gavi support | Africa | New and underutilized vaccines | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNIZATION | IMMUNOLOGY | Influenza vaccines | Hepatitis | Medical research | World health | Medicine, Experimental | Developing countries | Epidemiology | Rubella | Human papillomavirus | Immunization | Historical account | Measles | Influenza | Vaccines | Mumps | Children | Hepatitis B virus | Hepatitis B
Journal Article
Human Vaccines, ISSN 1554-8600, 12/2011, Volume 7, Issue 12, pp. 1343 - 1358
Journal Article